Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG study
| Title: | Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG study |
|---|---|
| Authors: | Payen, T., Trédaniel, J., Moreau, L., Larivé, S., Le Treut, J., Nocent, C., Hominal, S., Grangeon, V., Bizec, J.-L., Molinier, O., Debieuvre, D. |
| Source: | In Respiratory Medicine and Research November 2021 80 |
| Database: | ScienceDirect |
| ISSN: | 25900412 |
|---|---|
| DOI: | 10.1016/j.resmer.2020.100795 |
| Published in: | Respiratory Medicine and Research |
| Language: | English |